MedPath

Calcium Chloride

Approved
Approval ID

8295039b-2559-4626-90c8-6ac7e896e41a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 7, 2023

Manufacturers
FDA

International Medication Systems, Limited

DUNS: 055750020

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Calcium Chloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76329-3304
Application NumberANDA203477
Product Classification
M
Marketing Category
C73584
G
Generic Name
Calcium Chloride
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAVENTRICULAR
Effective DateMay 23, 2018
FDA Product Classification

INGREDIENTS (3)

Hydrochloric AcidInactive
Code: QTT17582CB
Classification: IACT
CALCIUM CHLORIDEActive
Quantity: 100 mg in 1 mL
Code: M4I0D6VV5M
Classification: ACTIB
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

Drug Labeling Information

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 7/7/2023

HOW SUPPLIED

10% Calcium Chloride Injection, USP is supplied in single-dose containers as follows:

NDC No.

Stock No.

Container Size

Needle

76329-3304-1

3304

10 mL

None

One shrink wrapped package containing 10 unit cartons, each containing a Luer- Jet™ Luer-Lock Prefilled Syringe.
Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F). [See USP Controlled Room Temperature.]

Syringe Assembly Directions:

USE ASEPTIC TECHNIQUE

Do not assemble until ready to use.

instruction

*CAUTION: IMPROPER ENGAGING MAY CAUSE GLASS BREAKAGE AND SUBSEQUENT INJURY.

PRECAUTIONS SECTION

LOINC: 42232-9Updated: 7/7/2023

PRECAUTIONS

Do not administer unless solution is clear and seal is intact. Discard unused portion.

Because of its additive effect, calcium should be administered very cautiously to a patient who is digitalized or who is taking effective doses of digitalis or digitalis-like preparations.

Injections should be made slowly through a small needle into a large vein to minimize venous irritation and avoid undesirable reactions. It is particularly important to prevent a high concentration of calcium from reaching the heart because of the danger of cardiac syncope.

Pediatric Use: Safety and effectiveness are based on similar clinical conditions in children and adults.

Pregnancy: Animal reproduction studies have not been conducted with calcium chloride. It also is not known whether calcium chloride can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Calcium chloride should be given to a pregnant woman only if clearly needed.

Geriatric Use: An evaluation of current literature revealed no clinical experience identifying differences in response between elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Calcium Chloride - FDA Drug Approval Details